Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1998 1
2001 1
2004 4
2007 1
2008 2
2009 2
2010 1
2011 5
2013 3
2014 3
2015 5
2016 2
2017 1
2018 3
2019 1
2021 1
2022 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Treatment optimization in multiple sclerosis.
Freedman MS, Patry DG, Grand'Maison F, Myles ML, Paty DW, Selchen DH; Canadian MS Working Group. Freedman MS, et al. Among authors: patry dg. Can J Neurol Sci. 2004 May;31(2):157-68. doi: 10.1017/s0317167100053804. Can J Neurol Sci. 2004. PMID: 15198439 Review.
The promise of futility trials in neurological diseases.
Koch MW, Korngut L, Patry DG, Agha-Khani Y, White C, Sarna JR, Yeung M, Yong VW, Heng DY, Cutter G, Metz L. Koch MW, et al. Among authors: patry dg. Nat Rev Neurol. 2015 May;11(5):300-5. doi: 10.1038/nrneurol.2015.34. Epub 2015 Mar 17. Nat Rev Neurol. 2015. PMID: 25776824 Review.
The Vaccine Communication Demands on Community-Based Workforces.
Rauh L, Patry D, Zambrano M, Lathan HS, Tavarez E, El-Mohandes A. Rauh L, et al. Among authors: patry d. Front Public Health. 2022 Feb 4;10:827378. doi: 10.3389/fpubh.2022.827378. eCollection 2022. Front Public Health. 2022. PMID: 35186850 Free PMC article.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Wolinsky JS, Narayana PA, Nelson F, Datta S, O'Connor P, Confavreux C, Comi G, Kappos L, Olsson TP, Truffinet P, Wang L, Miller A, Freedman MS; Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group. Wolinsky JS, et al. Mult Scler. 2013 Sep;19(10):1310-9. doi: 10.1177/1352458513475723. Epub 2013 Feb 27. Mult Scler. 2013. PMID: 23447359 Free article. Clinical Trial.
Interplay of Obesity, Ethanol, and Contaminant Mixture on Clinical Profiles of Cardiovascular and Metabolic Diseases: Evidence from an Animal Study.
Florian M, Li B, Patry D, Truong J, Caldwell D, Coughlan MC, Woodworth R, Yan J, Chen Q, Petrov I, Mahemuti L, Lalande M, Li N, Chan LHM, Willmore WG, Jin X. Florian M, et al. Among authors: patry d. Cardiovasc Toxicol. 2022 Jun;22(6):558-578. doi: 10.1007/s12012-022-09738-6. Epub 2022 Apr 16. Cardiovasc Toxicol. 2022. PMID: 35429258 Free PMC article.
38 results